| Patients n | 242 |
| IHD | |
| None | 161 (69) |
| Diagnosed by generalist | 18 (8) |
| Diagnosed by specialist | 19 (9) |
| Confirmed# | 34 (15) |
| Stroke or peripheral vascular disease | 34 (14) |
| Hypertension | 90 (37) |
| Hypercholesterolaemia | 76 (31) |
| Diabetes | 30 (12) |
| Family history of IHD | 76 (31) |
| Creatinine >120 μmol·L−1 | 24 (10) |
| Nonfasting lipids | |
| HDL cholesterol mmol·L−1 | 1.73±0.61 |
| Cholesterol/HDL ratio | 2.97±1.07 |
| Triglycerides mmol·L−1 | 1.45±0.87 |
| Nitrate or nicorandil | 35 (14) |
| Calcium channel blocker | 38 (16) |
| β-blocker | 5 (2) |
| ACE inhibitor/AR2 blocker | 44 (18) |
| Diuretic | 82 (34) |
| Statin therapy | 85 (35) |
| Antiplatelet therapy | 96 (40) |
| Antidiabetic therapy | 13 (5) |
Data are presented as n (%) or mean±sd, unless otherwise stated. IHD: ischaemic heart disease; HDL: high-density lipoprotein; ACE: angiotensin-converting enzyme; AR: angiotensin receptor. #: through diagnostic exercise tolerance testing, angiography or proven myocardial infarction.